About Decipher Labs Limited
Data last updated: 12 March 2026
Decipher Labs Limited is a public limited company based in Shaikpet, Telangana, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 17 September 1986, the company has been in operation for over 40 years.
Registered with ROC Hyderabad under CIN L24230TG1986PLC006781. Listed on BSE: 524752.
Capital: an authorised share capital of ₹10.5 Cr and a paid-up capital of ₹10.1 Cr. Formerly known as R. A. Labs (India) Limited and Ra Labs Limited. It is led by directors including Gayathri Raghuram and Sushant Mohan Lal.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: A – 2 Q2 5Th Floor Cyber Towers Hitech City, Shaikpet, Telangana, India – 500081.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.93 Cr, a decline of 34% compared to the previous year.
Its group structure includes 1 subsidiary.
The company is associated with 2 brands - Combat Drugs, Decipher Labs. As per MCA filings, the company has open charges of ₹42.25 Lakh and satisfied charges of ₹1.4 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website decipherlabs.in.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered AddressA – 2 Q2 5Th Floor Cyber Towers Hitech City, Shaikpet, Telangana, India – 500081
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Decipher Labs Limited
Decipher Labs Limited has undergone 11 name changes throughout its history. The current legal name is Decipher Labs Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Decipher Labs Limited | Current |
| R. A. Labs (India) Limited | Previous |
| Ra Labs Limited | Previous |
| R.A Labs (India) Limited | Previous |
| R.A. Labs Limited | Previous |
| Combat Drugs Limited | Previous |
| Ra Labs (India) Limited | Previous |
| Combat Drugs And Softech Limited | Previous |
| R.A Labs Limited | Previous |
| 3I Labs Limited | Previous |
| 3Rd I. Labs Limited | Previous |
| R.A. Labs (India) Limited | Previous |
CIN History of Decipher Labs Limited
Decipher Labs Limited has one previous CIN (Corporate Identification Number): L24230AP1986PLC006781. The current CIN is L24230TG1986PLC006781, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24230TG1986PLC006781 | Current |
| L24230AP1986PLC006781 | Previous |
Associated Brands with Decipher Labs Limited
Decipher Labs Limited operates two associated brands: Combat Drugs and Decipher Labs. These brands represent Decipher Labs Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Formulations are manufactured and custom services are provided in pharmaceuticals. | combatdrugs.in | |
| Healthcare company that develops and commercializes genomic tests for personalized cancer treatment, focusing on prostate and bladder cancer diagnosis and treatment planning | decipherlabs.in |
Competitors & Alternatives of Decipher Labs Limited
Brands and companies operating in the same space as Decipher Labs Limited include WuXi AppTec, ANI Pharmaceuticals, Aptar and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
WuXi AppTec
|
Provider of CRO and CDMO services | Shanghai, China, China | 2000 |
ANI Pharmaceuticals
|
Branded and generic prescription drugs are developed, manufactured, and marketed. | Baudette, United States, United States | 1996 |
Aptar
|
Regulatory support, brand differentiation, and prototyping services are provided. | Crystal Lake, United States, United States | 1992 |
CHEPLAPHARM
|
Branded pharmaceutical products are developed, marketed, and distributed globally. | Mesekenhagen, Germany, Germany | 1998 |
Red Nucleus
|
Advisory, scientific, and medical communications provided for pharmaceutical industry. | Yardley, United States, United States | 2014 |
Ipsen
|
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes | - | 1929 |
Eurofins Scientific
|
Laboratory testing and contract research services are provided globally. | Luxembourg, Luxembourg, Luxembourg | 1987 |
China Medical System
|
Generic formulations including tablets, capsules, liquids, and injectables are manufactured. | Shenzhen, China, China | 1992 |
Aliada Therapeutics
|
Provider of drug research & development services for multiple therapeutic areas | Boston, United States, United States | 2021 |
Business Activity of Decipher Labs Limited
Decipher Labs Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Decipher Labs Limited
Decipher Labs Limited is audited by M/s. Ramanatham & Co. (ICAI peer reviewed, certificate valid till 2026-05-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| M/s. Ramanatham & Co. (ICAI peer reviewed, certificate valid till 2026-05-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Decipher Labs Limited
Decipher Labs Limited is currently managed by 8 directors, with 19 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gayathri Raghuram | Director | 04 Sep 2023 | 2 Years 10 Months | Current |
|
Sushant Mohan Lal
Also directs:
Gincom Ventures Llp
|
Director | 19 May 2006 | 20 Years 1 Months | Current |
| Venkateswara Rao Gudipudi | Director | 13 Aug 2022 | 3 Years 10 Months | Current |
| Lakshmi Vijaya Nimmala | Director | 14 Feb 2023 | 3 Years 4 Months | Current |
|
Janaki Ram Ajjarapu
Also directs:
Icp Solutions Limited
|
Director | 14 Feb 2023 | 3 Years 4 Months | Current |
| Dalavath Amarsingh | Additional Director | 13 Nov 2025 | 0 Years 7 Months | Current |
Financials of Decipher Labs Limited FY 2026 filings available
Decipher Labs Limited reported revenue of ₹14.05 Cr (down 37.85% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹14.05 Cr | ₹22.61 Cr | ₹35.88 Cr | ₹45.57 Cr | ₹65.32 Cr | ₹55.56 Cr | ₹23.99 Cr | ₹8.06 Cr |
| Other Income | ₹22.09 Lakh | ₹1.32 Cr | ₹41.65 Lakh | ₹7.37 Cr | ₹7.67 Cr | ₹64.56 Lakh | ₹27.29 Lakh | ₹0 |
| Total Income | ₹14.27 Cr | ₹23.93 Cr | ₹36.3 Cr | ₹52.94 Cr | ₹73 Cr | ₹56.21 Cr | ₹24.26 Cr | ₹8.06 Cr |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹6.15 Cr |
| Purchases of Stock-in-Trade | ₹64.5 Lakh | ₹67.25 Lakh | ₹3.14 Cr | ₹47.25 Lakh | ₹15.53 Lakh | ₹15.04 Lakh | ₹61.85 Lakh | ₹0 |
| Changes in Inventories | -₹40,000 | ₹0 | ₹0 | ₹4.42 Lakh | ₹0 | ₹27.45 Lakh | ₹28,000 | -₹22.42 Lakh |
| Employee Benefit Expense | ₹14.99 Cr | ₹21.39 Cr | ₹27.75 Cr | ₹41.19 Cr | ₹47.49 Cr | ₹47.48 Cr | ₹19.57 Cr | ₹1.1 Cr |
| Finance Costs | ₹0 | ₹0 | ₹21.76 Lakh | ₹42.69 Lakh | ₹47.66 Lakh | ₹1.13 Cr | ₹72.15 Lakh | ₹0 |
| Depreciation & Amortisation | ₹51.63 Lakh | ₹47.63 Lakh | ₹45.27 Lakh | ₹42.75 Lakh | ₹86.66 Lakh | ₹81.93 Lakh | ₹55.61 Lakh | ₹6,000 |
| Other Expenses | ₹1.82 Cr | ₹7.78 Cr | ₹5.95 Cr | ₹12.3 Cr | ₹11.66 Cr | ₹4.2 Cr | ₹1.32 Cr | ₹59.61 Lakh |
| Total Expenses | ₹17.96 Cr | ₹30.32 Cr | ₹37.51 Cr | ₹54.86 Cr | ₹60.64 Cr | ₹54.06 Cr | ₹22.79 Cr | ₹7.62 Cr |
| Profit Before Exceptional Items & Tax | -₹3.68 Cr | -₹6.39 Cr | -₹1.21 Cr | -₹1.92 Cr | ₹12.36 Cr | ₹2.14 Cr | ₹1.47 Cr | ₹44.08 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | -₹2.24 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹3.68 Cr | -₹6.39 Cr | -₹1.21 Cr | -₹4.16 Cr | ₹12.36 Cr | ₹2.14 Cr | ₹1.47 Cr | ₹44.08 Lakh |
| Total Tax Expense | -₹60.06 Lakh | -₹1.31 Cr | ₹46.45 Lakh | -₹1.48 Cr | ₹97.22 Lakh | ₹74.03 Lakh | ₹36.52 Lakh | ₹3.54 Lakh |
| Net Profit | -₹3.08 Cr | -₹5.08 Cr | -₹1.68 Cr | -₹95.66 Lakh | ₹11.94 Cr | ₹1.4 Cr | ₹1.1 Cr | ₹40.54 Lakh |
| attributable to Owners | - | -₹5.08 Cr | - | ₹0 | - | ₹0 | ₹0 | ₹0 |
| attributable to NCI | - | ₹0 | - | ₹0 | - | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | ₹89.37 Lakh | ₹16.67 Lakh | ₹32.77 Lakh | ₹0 | ₹0 | -₹27.57 Lakh | ₹49.66 Lakh | ₹10,000 |
| Total Comprehensive Income | -₹2.19 Cr | -₹4.91 Cr | -₹1.35 Cr | -₹95.66 Lakh | ₹11.94 Cr | ₹1.13 Cr | ₹1.6 Cr | ₹40.64 Lakh |
| EBITDA (computed) | -₹3.17 Cr | -₹5.91 Cr | -₹54.08 Lakh | -₹1.06 Cr | ₹13.7 Cr | ₹4.1 Cr | ₹2.74 Cr | ₹44.14 Lakh |
| Basic EPS | ₹-3.05 | ₹-5.03 | ₹-1.66 | ₹-2.66 | ₹11.27 | ₹1.39 | ₹0.11 | ₹0.51 |
| Diluted EPS | ₹-3.05 | ₹-5.03 | ₹-1.66 | ₹-2.66 | ₹11.27 | ₹1.39 | ₹0.11 | ₹0.51 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹9 Cr | ₹25.76 Cr | ₹33.63 Cr | ₹28.16 Cr | ₹41.95 Cr | ₹38.72 Cr | ₹11.65 Cr | ₹6.34 Cr |
| Non-current Assets | ₹8.83 Cr | ₹4.71 Cr | ₹8.96 Cr | ₹8.08 Cr | ₹3.72 Cr | ₹16.18 Cr | ₹8.52 Cr | ₹2.52 Lakh |
| Current Assets | ₹16.78 Lakh | ₹21.05 Cr | ₹24.68 Cr | ₹20.08 Cr | ₹38.23 Cr | ₹22.54 Cr | ₹3.13 Cr | ₹6.32 Cr |
| Property, Plant & Equipment | ₹12 Lakh | ₹82.83 Lakh | ₹88 Lakh | ₹96.63 Lakh | ₹33.47 Lakh | ₹48.65 Lakh | ₹10.83 Lakh | ₹70,000 |
| Inventories | ₹40,000 | ₹0 | ₹0 | ₹0 | ₹4.42 Lakh | ₹4.42 Lakh | ₹31.87 Lakh | ₹32.15 Lakh |
| Trade Receivables | ₹3.39 Lakh | ₹4.22 Cr | ₹7.8 Cr | ₹9.85 Cr | ₹12.79 Cr | ₹11.67 Cr | ₹17.45 Lakh | ₹3.46 Cr |
| Cash & Equivalents | ₹2.5 Lakh | ₹2.81 Cr | ₹9.31 Cr | ₹7.42 Cr | ₹15.41 Cr | ₹6.98 Cr | ₹0 | ₹57,000 |
| Equity (Net Worth) | ₹8.24 Cr | ₹22.86 Cr | ₹21.86 Cr | ₹23.21 Cr | ₹24.17 Cr | ₹13.69 Cr | ₹11.07 Cr | ₹2.53 Cr |
| Equity Share Capital | ₹10.1 Cr | ₹10.1 Cr | ₹10.1 Cr | ₹10.1 Cr | ₹10.1 Cr | ₹10.1 Cr | ₹10.1 Cr | ₹8 Cr |
| Borrowings (Non-current) | ₹0 | ₹0 | ₹0 | ₹94.94 Lakh | ₹6.67 Cr | ₹6.71 Cr | ₹0 | ₹0 |
| Borrowings (Current) | ₹50.32 Lakh | ₹24.45 Lakh | ₹0 | ₹0 | ₹3.65 Cr | ₹2.04 Cr | ₹23.04 Lakh | ₹20.08 Lakh |
| Total Debt (computed) | ₹50.32 Lakh | ₹24.45 Lakh | ₹0 | ₹94.94 Lakh | ₹10.32 Cr | ₹8.76 Cr | ₹23.04 Lakh | ₹20.08 Lakh |
| Current Liabilities | ₹75.46 Lakh | ₹2.91 Cr | ₹11.77 Cr | ₹4.01 Cr | ₹11.11 Cr | ₹17.31 Cr | ₹58.34 Lakh | ₹3.82 Cr |
| Total Liabilities | ₹75.46 Lakh | ₹2.91 Cr | ₹11.77 Cr | ₹4.96 Cr | ₹17.78 Cr | ₹25.03 Cr | ₹58.34 Lakh | ₹3.82 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | -₹2.08 Cr | -₹9.82 Cr | ₹4.85 Cr | -₹1.56 Cr | ₹8.26 Cr |
| Investing Cash Flow | -₹24.09 Lakh | ₹3.07 Cr | -₹1.79 Cr | -₹4.28 Cr | -₹45.33 Lakh |
| Financing Cash Flow | ₹25.86 Lakh | ₹24.45 Lakh | -₹1.17 Cr | -₹2.15 Cr | ₹62.13 Lakh |
| Capital Expenditure | ₹24.09 Lakh | ₹5.69 Lakh | ₹5.84 Lakh | ₹78.3 Lakh | ₹19.92 Lakh |
| Free Cash Flow (computed) | -₹2.32 Cr | -₹9.88 Cr | ₹4.8 Cr | -₹2.35 Cr | ₹8.07 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹2.07 Cr | -₹6.51 Cr | ₹1.9 Cr | -₹7.99 Cr | ₹8.43 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹3.6 Cr | ₹3.21 Cr | ₹4.31 Cr | ₹2.92 Cr | ₹3.5 Cr | ₹5.8 Cr | ₹5.87 Cr | ₹7.44 Cr |
| Other Income | ₹17.37 Lakh | ₹1.55 Lakh | ₹2.05 Lakh | ₹1.12 Lakh | ₹87.05 Lakh | ₹16.87 Lakh | ₹12.09 Lakh | ₹15.81 Lakh |
| Total Income | ₹3.78 Cr | ₹3.23 Cr | ₹4.33 Cr | ₹2.93 Cr | ₹4.37 Cr | ₹5.97 Cr | ₹5.99 Cr | ₹7.6 Cr |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹40,000 | ₹0 | ₹0 | ₹64.1 Lakh | ₹23 Lakh | ₹15 Lakh | ₹0 | ₹29.25 Lakh |
| Changes in Inventories | -₹40,000 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹2.68 Cr | ₹3.54 Cr | ₹4.05 Cr | ₹4.73 Cr | ₹3.76 Cr | ₹5.83 Cr | ₹6.69 Cr | ₹5.11 Cr |
| Finance Costs | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Depreciation & Amortisation | ₹14.86 Lakh | ₹12.52 Lakh | ₹12.54 Lakh | ₹11.71 Lakh | ₹12.65 Lakh | ₹12.2 Lakh | ₹11.5 Lakh | ₹11.28 Lakh |
| Other Expenses | ₹69.93 Lakh | ₹10.09 Lakh | ₹14.26 Lakh | ₹87.3 Lakh | ₹6.08 Cr | ₹45.79 Lakh | ₹51.28 Lakh | ₹72.24 Lakh |
| Total Expenses | ₹3.53 Cr | ₹3.76 Cr | ₹4.32 Cr | ₹6.36 Cr | ₹10.2 Cr | ₹6.56 Cr | ₹7.32 Cr | ₹6.24 Cr |
| Profit Before Exceptional Items & Tax | ₹25.16 Lakh | -₹53.31 Lakh | ₹1.89 Lakh | -₹3.42 Cr | -₹5.83 Cr | -₹58.47 Lakh | -₹1.33 Cr | ₹1.36 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹25.16 Lakh | -₹53.31 Lakh | ₹1.89 Lakh | -₹3.42 Cr | -₹5.83 Cr | -₹58.47 Lakh | -₹1.33 Cr | ₹1.36 Cr |
| Total Tax Expense | ₹60.95 Lakh | ₹57,000 | -₹12,000 | ₹44,000 | -₹1.73 Cr | ₹80,000 | ₹6,000 | ₹41.13 Lakh |
| Net Profit | -₹35.79 Lakh | -₹53.88 Lakh | ₹2.01 Lakh | -₹3.43 Cr | -₹4.11 Cr | -₹59.27 Lakh | -₹1.33 Cr | ₹94.66 Lakh |
| attributable to Owners | - | -₹53.88 Lakh | ₹2.01 Lakh | -₹3.43 Cr | -₹4.11 Cr | -₹59.27 Lakh | -₹38.14 Lakh | - |
| attributable to NCI | - | ₹0 | - | - | ₹0 | ₹0 | - | - |
| Other Comprehensive Income | ₹88.55 Lakh | ₹31.45 Lakh | -₹59.08 Lakh | ₹28.45 Lakh | -₹33.47 Lakh | ₹22.12 Lakh | ₹28.26 Lakh | -₹24,000 |
| Total Comprehensive Income | ₹52.76 Lakh | -₹22.43 Lakh | -₹57.07 Lakh | -₹3.14 Cr | -₹4.44 Cr | -₹37.15 Lakh | -₹1.05 Cr | ₹94.42 Lakh |
| EBITDA (computed) | ₹40.02 Lakh | -₹40.79 Lakh | ₹14.43 Lakh | -₹3.31 Cr | -₹5.71 Cr | -₹46.27 Lakh | -₹1.21 Cr | ₹1.47 Cr |
| Basic EPS | ₹-0.35 | ₹-0.53 | ₹0.02 | ₹-3.39 | ₹-4.07 | ₹-0.59 | ₹-1.31 | ₹0.94 |
| Diluted EPS | ₹-0.35 | ₹-0.53 | ₹0.02 | ₹-3.39 | ₹-4.07 | ₹-0.59 | ₹-1.31 | ₹0.94 |
| Segment · Q4 FY26 (latest quarter) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Manufacturing and Trading of Pharmaceutical drugs | ₹0 | ₹7.73 Lakh | ₹9.14 Cr | ₹75.47 Lakh |
| Consultancy Services | ₹3.6 Cr | ₹17.44 Lakh | ₹15.2 Cr | ₹2.91 Cr |
| Segment · FY 2026 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Manufacturing and Trading of Pharmaceutical drugs | ₹67.5 Lakh | -₹17.7 Lakh | - | - |
| Consultancy Services | ₹13.38 Cr | -₹3.51 Cr | - | - |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹1.14 Cr | ₹85.32 Lakh | ₹3.53 Cr | ₹81 Lakh | ₹98.84 Lakh | ₹97.6 Lakh | ₹1.42 Cr | ₹6.78 Cr |
| Other Income | ₹13,000 | ₹2.28 Lakh | ₹1.99 Lakh | ₹2.82 Lakh | ₹4.59 Lakh | ₹14.43 Lakh | ₹1.32 Lakh | ₹88,000 |
| Total Income | ₹1.14 Cr | ₹87.6 Lakh | ₹3.55 Cr | ₹83.82 Lakh | ₹1.03 Cr | ₹1.12 Cr | ₹1.44 Cr | ₹6.79 Cr |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹6.15 Cr |
| Purchases of Stock-in-Trade | ₹64.5 Lakh | ₹67.25 Lakh | ₹3.14 Cr | ₹47.25 Lakh | ₹15.53 Lakh | ₹15.04 Lakh | ₹61.85 Lakh | ₹0 |
| Changes in Inventories | -₹40,000 | ₹0 | ₹0 | ₹4.42 Lakh | ₹0 | ₹27.44 Lakh | ₹28,000 | -₹22.42 Lakh |
| Employee Benefit Expense | ₹17.53 Lakh | ₹23.43 Lakh | ₹16.99 Lakh | ₹20.11 Lakh | ₹23.32 Lakh | ₹19.85 Lakh | ₹32.01 Lakh | ₹16.68 Lakh |
| Finance Costs | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹1.79 Lakh | ₹0 | ₹0 |
| Depreciation & Amortisation | ₹1.8 Lakh | ₹1.67 Lakh | ₹1.45 Lakh | ₹5.74 Lakh | ₹5.01 Lakh | ₹4.15 Lakh | ₹35,000 | ₹6,000 |
| Other Expenses | ₹54.07 Lakh | ₹39.14 Lakh | ₹20.42 Lakh | ₹46.03 Lakh | ₹23.78 Lakh | ₹33.72 Lakh | ₹32.43 Lakh | ₹32.25 Lakh |
| Total Expenses | ₹1.38 Cr | ₹1.31 Cr | ₹3.53 Cr | ₹1.24 Cr | ₹67.64 Lakh | ₹1.02 Cr | ₹1.27 Cr | ₹6.41 Cr |
| Profit Before Exceptional Items & Tax | -₹23.83 Lakh | -₹43.89 Lakh | ₹2.52 Lakh | -₹39.73 Lakh | ₹35.79 Lakh | ₹10.04 Lakh | ₹16.75 Lakh | ₹37.69 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | -₹2.24 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹23.83 Lakh | -₹43.89 Lakh | ₹2.52 Lakh | -₹2.64 Cr | ₹35.79 Lakh | ₹10.04 Lakh | ₹16.75 Lakh | ₹37.69 Lakh |
| Total Tax Expense | ₹85,000 | ₹13,000 | ₹18,000 | -₹2.14 Lakh | -₹25,000 | ₹42,000 | -₹5,000 | ₹1,000 |
| Net Profit | -₹24.68 Lakh | -₹44.02 Lakh | ₹2.34 Lakh | -₹2.62 Cr | ₹36.04 Lakh | ₹9.62 Lakh | ₹16.8 Lakh | ₹37.68 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹24.68 Lakh | -₹44.02 Lakh | ₹2.34 Lakh | -₹2.62 Cr | ₹36.04 Lakh | ₹9.62 Lakh | ₹16.8 Lakh | ₹37.68 Lakh |
| EBITDA (computed) | -₹22.03 Lakh | -₹42.22 Lakh | ₹3.97 Lakh | -₹33.99 Lakh | ₹40.8 Lakh | ₹15.98 Lakh | ₹17.1 Lakh | ₹37.75 Lakh |
| Basic EPS | ₹-0.24 | ₹-0.44 | ₹0.02 | ₹-2.59 | ₹0.36 | ₹0.10 | ₹0.17 | ₹0.47 |
| Diluted EPS | ₹-0.24 | ₹-0.44 | ₹0.02 | ₹-2.59 | ₹0.36 | ₹0.10 | ₹0.17 | ₹0.47 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹9 Cr | ₹9.18 Cr | ₹12.76 Cr | ₹8.99 Cr | ₹11.6 Cr | ₹11.4 Cr | ₹11.65 Cr | ₹5.84 Cr |
| Non-current Assets | ₹8.83 Cr | ₹8.85 Cr | ₹8.79 Cr | ₹8.81 Cr | ₹9 Cr | ₹8.67 Cr | ₹8.52 Cr | ₹5.56 Lakh |
| Current Assets | ₹16.78 Lakh | ₹32.44 Lakh | ₹3.97 Cr | ₹18.4 Lakh | ₹2.6 Cr | ₹2.73 Cr | ₹3.13 Cr | ₹5.78 Cr |
| Property, Plant & Equipment | ₹12 Lakh | ₹13.8 Lakh | ₹10.43 Lakh | ₹11.87 Lakh | ₹33.46 Lakh | ₹25.55 Lakh | ₹10.83 Lakh | ₹70,000 |
| Inventories | ₹40,000 | ₹0 | ₹0 | ₹0 | ₹4.42 Lakh | ₹4.42 Lakh | ₹31.87 Lakh | ₹32.15 Lakh |
| Trade Receivables | ₹3.39 Lakh | ₹22.68 Lakh | ₹3.95 Cr | ₹12.74 Lakh | ₹21.54 Lakh | ₹41.42 Lakh | ₹17.45 Lakh | ₹3.04 Cr |
| Cash & Equivalents | ₹2.5 Lakh | ₹5.47 Lakh | ₹2.65 Lakh | ₹5.63 Lakh | ₹4.76 Lakh | ₹1.93 Lakh | ₹0 | ₹55,000 |
| Equity (Net Worth) | ₹8.24 Cr | ₹8.49 Cr | ₹8.93 Cr | ₹8.9 Cr | ₹11.52 Cr | ₹11.16 Cr | ₹11.07 Cr | ₹2.5 Cr |
| Equity Share Capital | ₹10.1 Cr | ₹10.1 Cr | ₹10.1 Cr | ₹10.1 Cr | ₹10.1 Cr | ₹10.1 Cr | ₹10.1 Cr | ₹8 Cr |
| Borrowings (Non-current) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Borrowings (Current) | ₹50.32 Lakh | ₹24.45 Lakh | ₹0 | ₹0 | ₹0 | ₹13.63 Lakh | ₹23.04 Lakh | ₹13.87 Lakh |
| Total Debt (computed) | ₹50.32 Lakh | ₹24.45 Lakh | ₹0 | ₹0 | ₹0 | ₹13.63 Lakh | ₹23.04 Lakh | ₹13.87 Lakh |
| Current Liabilities | ₹75.46 Lakh | ₹69.09 Lakh | ₹3.83 Cr | ₹8.55 Lakh | ₹8.04 Lakh | ₹23.19 Lakh | ₹58.34 Lakh | ₹3.34 Cr |
| Total Liabilities | ₹75.46 Lakh | ₹69.09 Lakh | ₹3.83 Cr | ₹8.55 Lakh | ₹8.18 Lakh | ₹23.57 Lakh | ₹58.34 Lakh | ₹3.34 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | -₹28.84 Lakh | ₹7.49 Lakh | -₹2.95 Lakh | -₹7.64 Lakh | ₹54.78 Lakh |
| Investing Cash Flow | ₹0 | -₹4.67 Lakh | ₹0 | ₹8.5 Lakh | -₹38.32 Lakh |
| Financing Cash Flow | ₹25.87 Lakh | ₹0 | ₹0 | ₹0 | -₹13.63 Lakh |
| Capital Expenditure | ₹0 | ₹5.69 Lakh | ₹0 | -₹8.5 Lakh | ₹12.91 Lakh |
| Free Cash Flow (computed) | -₹28.84 Lakh | ₹1.8 Lakh | -₹2.95 Lakh | -₹16.14 Lakh | ₹41.87 Lakh |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹2.97 Lakh | ₹2.82 Lakh | -₹2.95 Lakh | ₹86,000 | ₹2.83 Lakh |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹6.69 Lakh | ₹13.4 Lakh | ₹8.8 Lakh | ₹84.65 Lakh | ₹22.6 Lakh | ₹16 Lakh | ₹8.38 Lakh | ₹38.34 Lakh |
| Other Income | ₹11,000 | ₹0 | ₹2,000 | ₹0 | ₹1,000 | ₹33,000 | ₹1.77 Lakh | ₹17,000 |
| Total Income | ₹6.8 Lakh | ₹13.4 Lakh | ₹8.82 Lakh | ₹84.65 Lakh | ₹22.61 Lakh | ₹16.33 Lakh | ₹10.15 Lakh | ₹38.51 Lakh |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹40,000 | ₹0 | ₹0 | ₹64.1 Lakh | ₹23 Lakh | ₹15 Lakh | ₹0 | ₹29.25 Lakh |
| Changes in Inventories | -₹40,000 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹5.32 Lakh | ₹4.51 Lakh | ₹3.85 Lakh | ₹3.85 Lakh | ₹8.3 Lakh | ₹3.01 Lakh | ₹4.4 Lakh | ₹7.72 Lakh |
| Finance Costs | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Depreciation & Amortisation | ₹45,000 | ₹45,000 | ₹45,000 | ₹45,000 | ₹45,000 | ₹45,000 | ₹45,000 | ₹32,000 |
| Other Expenses | ₹18.38 Lakh | ₹9.28 Lakh | ₹16.19 Lakh | ₹10.22 Lakh | ₹7.3 Lakh | ₹6.96 Lakh | ₹11.05 Lakh | ₹13.83 Lakh |
| Total Expenses | ₹24.15 Lakh | ₹14.24 Lakh | ₹20.49 Lakh | ₹78.62 Lakh | ₹39.05 Lakh | ₹25.42 Lakh | ₹15.9 Lakh | ₹51.12 Lakh |
| Profit Before Exceptional Items & Tax | -₹17.35 Lakh | -₹84,000 | -₹11.67 Lakh | ₹6.03 Lakh | -₹16.44 Lakh | -₹9.09 Lakh | -₹5.75 Lakh | -₹12.61 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹17.35 Lakh | -₹84,000 | -₹11.67 Lakh | ₹6.03 Lakh | -₹16.44 Lakh | -₹9.09 Lakh | -₹5.75 Lakh | -₹12.61 Lakh |
| Total Tax Expense | -₹4,000 | ₹57,000 | -₹12,000 | ₹44,000 | ₹37,000 | -₹12,000 | -₹11,000 | ₹47,000 |
| Net Profit | -₹17.31 Lakh | -₹1.41 Lakh | -₹11.55 Lakh | ₹5.59 Lakh | -₹16.81 Lakh | -₹8.97 Lakh | -₹5.64 Lakh | -₹13.08 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹17.31 Lakh | -₹1.41 Lakh | -₹11.55 Lakh | ₹5.59 Lakh | -₹16.81 Lakh | -₹8.97 Lakh | -₹5.64 Lakh | -₹13.08 Lakh |
| EBITDA (computed) | -₹16.9 Lakh | -₹39,000 | -₹11.22 Lakh | ₹6.48 Lakh | -₹15.99 Lakh | -₹8.64 Lakh | -₹5.3 Lakh | -₹12.29 Lakh |
| Basic EPS | ₹-0.17 | ₹-0.01 | ₹-0.11 | ₹0.06 | ₹-0.17 | ₹-0.09 | ₹-0.06 | ₹-0.13 |
| Diluted EPS | ₹-0.17 | ₹-0.01 | ₹-0.11 | ₹0.06 | ₹-0.17 | ₹-0.09 | ₹-0.06 | ₹-0.13 |
| Segment · Q4 FY26 (latest quarter) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Manufacturing and Trading of Pharmaceutical drugs | ₹0 | -₹10.07 Lakh | ₹9 Cr | ₹75.47 Lakh |
| Consultancy Services | ₹6.69 Lakh | -₹7.28 Lakh | ₹0 | ₹0 |
| Segment · FY 2026 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Manufacturing and Trading of Pharmaceutical drugs | ₹67.5 Lakh | -₹14.17 Lakh | - | - |
| Consultancy Services | ₹46.04 Lakh | -₹9.66 Lakh | - | - |
Shareholding Pattern of Decipher Labs Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 16.43%, foreign institutional investors hold 0.00%, retail and other public shareholders hold 83.57% of Decipher Labs Limited. The company had 29,596 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 16.43% | 16.43% | 16.43% | 16.43% | 16.43% | 16.43% |
| Public | 83.57% | 83.57% | 83.57% | 83.57% | 83.57% | 83.57% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 16.43% | 16.43% | 16.43% |
| Public | 83.57% | 83.57% | 83.57% |
| Promoter change (YoY, %pts) | +0.00 | +0.00 | - |
Group Structure of Decipher Labs Limited
Decipher Labs Limited has 1 subsidiary company. This group structure data is as of FY 2021. The corporate group structure reflects Decipher Labs Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Icp Solutions Private Limited | U72500TG2018PTC124743 | - |
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Decipher Labs Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Nov 1996 | The Dhanlakshmi Bank Ltd | ₹40 Lakh | Open |
| 07 Feb 1989 | Corporation Bank | ₹2.25 Lakh | Open |
| 16 Jul 1997 | Vijaya Bank | ₹40 Lakh | Satisfied |
| 21 Nov 1996 | The Dhanlakshmi Bank Ltd | ₹40 Lakh | Satisfied |
| 07 May 1996 | The Dhanlakshmi Bank Ltd | ₹60 Lakh | Satisfied |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Decipher Labs Limited
View historical data on people associated with Decipher Labs Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Decipher Labs Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Decipher Labs Limited
GSTIN & GST Filing Data of Decipher Labs Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Decipher Labs Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Decipher Labs Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Decipher Labs Limited
MSME Payment Delays by Decipher Labs Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Decipher Labs Limited
Subsidiaries & Group Companies of Decipher Labs Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Decipher Labs Limited with ownership details.
MCA Filings & Documents of Decipher Labs Limited
MCA Filings & Documents of Decipher Labs Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Decipher Labs Limited
Recent News on Decipher Labs Limited
Frequently Asked Questions about Decipher Labs Limited
Decipher Labs Limited is an active public limited company in the pharma sector based in Shaikpet, Telangana, India. It was incorporated on 17 September 1986 (40+ years old) and is registered under CIN L24230TG1986PLC006781. Listed on BSE: 524752.
Decipher Labs Limited reported revenue of ₹23.93 Cr for FY 2025 (down 34.00% YoY).
The current directors of Decipher Labs Limited are:
- Gayathri Raghuram
- Sushant Mohan Lal
- Sonam Jalan
- Venkateswara Rao Gudipudi
- Lakshmi Vijaya Nimmala
- Janaki Ram Ajjarapu
- Preeti Singh
- Dalavath Amarsingh
The primary industry of Decipher Labs Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Yes. Decipher Labs Limited is listed on BSE with code 524752.
Decipher Labs Limited can be reached at the registered office: A – 2 Q2 5Th Floor Cyber Towers Hitech City, Shaikpet, Telangana, India – 500081, or through the website decipherlabs.in.